Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection

Ebola fever is an acute, highly contagious viral disease with a mortality rate that can reach 90%. There are currently no licensed therapeutic agents specific to Ebola in the world. Monoclonal antibodies (MAbs) with viral-neutralizing activity and high specificity to the Ebola virus glycoprotein (EB...

Descripción completa

Detalles Bibliográficos
Autores principales: Esmagambetov, I. B., Shcheblyakov, D. V., Egorova, D. A., Voronina, O. L., Derkaev, A. A., Voronina, D. V., Popova, O., Ryabova, E. I., Shcherbinin, D. N., Aksenova, E. I., Semenov, A. N., Kunda, M. S., Ryzhova, N. N., Zubkova, O. V., Tukhvatulin, A. I., Logunov, D. Yu., Naroditsky, B. S., Borisevich, S. V., Gintsburg, A. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: A.I. Gordeyev 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807537/
https://www.ncbi.nlm.nih.gov/pubmed/35127147
http://dx.doi.org/10.32607/actanaturae.11487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807537/
https://www.ncbi.nlm.nih.gov/pubmed/35127147
http://dx.doi.org/10.32607/actanaturae.11487

Ejemplares similares